Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

JOURNAL ARTICLE published December 2013 in The Lancet Oncology

Authors: Yasuhide Yamada | Daisuke Takahari | Hiroshi Matsumoto | Hideo Baba | Masato Nakamura | Kazuhiro Yoshida | Motoki Yoshida | Shigeyoshi Iwamoto | Ken Shimada | Yoshito Komatsu | Yasutsuna Sasaki | Taroh Satoh | Keiichi Takahashi | Hideyuki Mishima | Kei Muro | Masahiko Watanabe | Yuh Sakata | Satoshi Morita | Yasuhiro Shimada | Kenichi Sugihara